Latest News about GSK
Recent news which mentions GSK
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
From Benzinga
Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy
August 09, 2022
From Benzinga
From Benzinga
3 Fast-Growing Stocks to Buy Now
July 31, 2022
From Motley Fool
2 Biotech Stocks That Could Help Make You a Fortune
July 30, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
IDEAYA's Cancer Candidate Shows Early Tumor Modulation
July 27, 2022
From Benzinga
Paxlovid has been given to Biden and millions of Americans infected with COVID-19. In the U.K., it sits on the shelf.
July 27, 2022
From MarketWatch
The 3 Best Market Sectors for the Second Half of 2022
July 27, 2022
From InvestorPlace
From Benzinga
Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2
July 27, 2022
From Benzinga
From Benzinga
New GSK Q2 Highlights: Shingles Vaccine Back In Demand, Antibiotics Recover, Forecast Boost
July 27, 2022
Tickers
GSK
From Benzinga
7 Dividend Stocks to Buy on the Dip
July 27, 2022
From InvestorPlace
From Benzinga
3 Biotech Stocks to Buy on the Dip
July 21, 2022
From InvestorPlace
From Benzinga
Post Mega London Stock Exchange Listing, GSK Spinoff Haleon's Plunge Brings Valuation Concerns To The Fore
July 19, 2022
From Benzinga
Codexis Shares Slide On CEO Transition
July 18, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
How Its New Vaccine Could Propel GSK's Growth
July 11, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.